Enhanced antiviral function of magnesium chloride-modified Heparin on a broad 
spectrum of viruses

Mese, K.; Bunz, O.; Volkwein, W.; Vemulapalli, S. P.; Zhang, W. L; Schellhorn, S.; Heenemann, K.; Rueckner, A.; Sing, A.; Vahlenkamp, T.W.; Severing, A. L.; Gao, J.; Aydin, M.; Jung, D.; Bachmann, H. S.; Zanker, K. S.; Busch, U.; Baiker, A.; Griesinger, C.; Griesinger, C.; Ehrhardt, A.

doi:10.3390/ijms221810075

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Bitte beachten Sie, dass eine neuere Version dieses Datensatzes verfügbar ist:
https://pure.mpg.de/pubman/item/item_3352528_3

DetailsÜbersicht

Freigegeben

Zeitschriftenartikel

Enhanced antiviral function of magnesium chloride-modified Heparin on a broad spectrum of viruses

MPG-Autoren

/persons/resource/persons246178

Vemulapalli, S. P.
Department of NMR Based Structural Biology, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger, C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

Externe Ressourcen

Es sind keine externen Ressourcen hinterlegt

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

3352528.pdf
(Verlagsversion), 2MB

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Mese, K., Bunz, O., Volkwein, W., Vemulapalli, S. P., Zhang, W. L., Schellhorn, S., et al. (2021). Enhanced antiviral function of magnesium chloride-modified Heparin on a broad spectrum of viruses. Journal of Molecular Sciences, 22(18): 10075. doi:10.3390/ijms221810075.

Zitierlink: https://hdl.handle.net/21.11116/0000-0009-8337-5

Zusammenfassung

Previous studies reported on the broad-spectrum antiviral function of heparin. Here we investigated the antiviral function of magnesium-modified heparin and found that modified heparin displayed a significantly enhanced antiviral function against human adenovirus (HAdV) in immortalized and primary cells. Nuclear magnetic resonance analyses revealed a conformational change of heparin when complexed with magnesium. To broadly explore this discovery, we tested the antiviral function of modified heparin against herpes simplex virus type 1 (HSV-1) and found that the replication of HSV-1 was even further decreased compared to aciclovir. Moreover, we investigated the antiviral effect against the new severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and measured a 55-fold decreased viral load in the supernatant of infected cells associated with a 38-fold decrease in virus growth. The advantage of our modified heparin is an increased antiviral effect compared to regular heparin.